|
Why AbbVie Stock Is Sinking and Allergan Is Soaring Today Motley FoolAbbVie looks beyond Humira with a $63 billion deal for Botox-maker Allergan CNBCAbbVie Strikes Deal to Buy Allergan for About $63 Billion The Wall Street JournalAllergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal Yahoo FinanceBotox Maker Allergan Is Sold to AbbVie in $63 Billion Deal The New York TimesView full coverage on Google News
|
RELATED ARTICLES | | |
|
AbbVie's $63 Billion Mistake Motley FoolAbbVie looks beyond Humira with a $63 billion deal for Botox-maker Allergan CNBCAbbVie Strikes Deal to Buy Allergan for About $63 Billion The Wall Street JournalAllergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal Yahoo FinanceBotox Maker Allergan Is Sold to AbbVie in $63 Billion Deal The New York TimesView full coverage on Google News
|
RELATED ARTICLES | | |
|
 Drugmaker AbbVie Inc said on
Tuesday it would buy Botox-maker Allergan Plc for about
$63 billion, grabbing control of by far the biggest name in
medical aesthetics to help reduce its reliance on blockbuster
arthritis treatment Humira.
|
|
 Fed Chairman Jerome Powell on Tuesday suggested an interest-rate cut in July was not a done deal.
|
|
Amazon Prime Day 2019: how to find the best deals on TVs and more The VergeAmazon Prime Day will actually be two days this year CNNPrime Day 2019 - A two-day parade of epic deals. amazonWindows Central Podcast 138: A new Cortana Windows CentralAmazon announced the date of Prime Day, and it sounds like Alibaba's Singles Day Yahoo FinanceView full coverage on Google News
|
RELATED ARTICLES | | |
|
 Stocks opened little changed Tuesday as investors awaited remarks by Federal Reserve Chairman Jerome Powell. The Dow Jones Industrial Average rose 13 points, or less than 0.1%, to 26,740, while the S&P 500 was down less than a point at 2,944. The Nasdaq Composite was off 0.1% at 7,997. Investor expectations for the Federal Reserve to deliver a rate cut as early as next month were boosted after last week's policy meeting and Powell's news conference. Powell will have the opportunity to affirm or soften those expectations when he speaks at 1 p.m. Eastern at the Council on Foreign Relations in New York. Shares of Allergan PLC jumped nearly 29% after agreeing to be bought by fellow drugmaker AbbVie Inc. in a deal valued at $63 billion. Abbvie shares fell 11.5%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Private Label